Search Results

of receptor activity-modifying proteins in obesity and diabetes mellitus Maleesha Ubhayarathna , Christopher Langmead , Gregory Stewart , et al. for their fantastic review on Molecular and structural insights into the 5-HT2C receptor as a therapeutic target for substance use disorders Leigh Walker , Christopher Langmead , Andrew Lawrence , et al. for their remarkable analysis on Targeting muscarinic receptors

Christopher Langmead and colleagues' work on the 5-HT2C receptor as a therapeutic target for substance

Che for their analysis of GPCR-G protein selectivity revealed by structural pharmacology Yao Lu, Drs Christopher Langmead,  Gregory Stewart, et al. for their study on Molecular insights into orphan G protein-coupled

GPCR Podcast Strategic Partners Chris Langmead Chris Langmead is Professor, Deputy Director, and Better Christopher Langmead on the web Monash University T witter Google Scholar Linkedin PubMed Monash Neuromedicines

My postdoctoral work, conducted at the University of Bristol, UK, in Christopher Lowry's lab, examined

Affiliations "Groff, Karenna; Donaldson, Hayley; Anderson, Sebastian; Pitti, Kiran; Wang, Shuai; Park, Christopher Mosharov1,2,4, David Sulzer1,2,4, Christoph Kellendonk1,2, and Jonathan A.